Related Experiment Videos
Drug therapy for hypertension and hyperlipidemia
1Department of Nephrology and Hypertension, Cleveland Clinic Foundation, Ohio, USA.
The Journal of Cardiovascular Nursing
|January 1, 1995
Summary
Hypertension and hyperlipidemia cause major vascular diseases, impacting health and costs. Early detection and treatment, using non-drug and drug methods, can reduce these conditions effectively.
Area of Science:
- Cardiovascular Medicine
- Public Health
Background:
- Hypertension and hyperlipidemia are primary drivers of coronary heart disease and vascular complications.
- These conditions contribute significantly to morbidity, mortality, and healthcare expenditures in the US.
Purpose of the Study:
- To discuss the appropriate detection, confirmation, evaluation, and treatment of individuals at risk for hypertension and hyperlipidemia.
- To highlight the importance of healthcare provider involvement in managing these vascular risk factors.
Main Methods:
- Review of current nonpharmacologic and pharmacologic treatment strategies.
- Focus on the clinical approach to identifying and managing at-risk patients.
Main Results:
- Nonpharmacologic and pharmacologic treatments have demonstrated success in mitigating vascular complications.
- Effective management strategies are crucial for reducing disease frequency and severity.
Conclusions:
- Comprehensive management, including early detection and tailored treatment, is essential for controlling hypertension and hyperlipidemia.
- Healthcare providers play a critical role in the successful management of these prevalent vascular conditions.